Former VP at Lonza Group AG
- Small molecule CDMO (contract development and manufacturing organisation) market overview and competitive positioning of major players
- Expected growth of small molecule outsourced manufacturing vs biologics
- Lonza's (VTX: LONN) divestment of its softgel business and Catalent's (NYSE: CTLT) divestment of its BFS (blow-fill-seal) business
- Expected pace of future divestments and potential acquirers or consolidators
- H2 2021 outlook
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.